![Khing Oei](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Khing Oei
Voorzitter bij
CYPHERPUNK TECHNOLOGIES INC.
Vermogen: 190 687 $ op 31-05-2026
Profiel
Khing Djien Oei is the founder of Treasury NV, founded in 2025, holding the title of Chief Executive Officer.
Mr. Oei was the founder of Eyck Capital Management LLP, founded in 2011, holding the title of Managing Partner.
Mr. Oei currently holds the position of Non-Executive Chairman at Cypherpunk Technologies, Inc. since 2025.
Former positions include Portfolio Manager at Drawbridge (UK) LLP from 2006 to 2006 and Managing Principal at Segovia Loan Advisors (UK) LLP from 2006 to 2011.
Education includes graduate studies at Vrije Universiteit Amsterdam.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 20-04-2026 | 168.750 ( 0,16% ) | 190 688 $ | 31-05-2026 |
Actieve functies van Khing Oei
| Bedrijven | Functie | Begin |
|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. | Voorzitter | 11-11-2025 |
Eerdere bekende functies van Khing Oei
| Bedrijven | Functie | Einde |
|---|---|---|
Segovia Loan Advisors (UK) LLP
 Segovia Loan Advisors (UK) LLP Investment ManagersFinance SLA UK manages various strategies across the capital structure, such as syndicated leveraged loans, high yield bonds, privately negotiated senior secured debt, mezzanine investments, asset-based leasing, and private equity. The firm seeks to provide creative capital solutions and generate attractive risk-adjusted returns for clients. | Director of Investments | 15-08-2011 |
Drawbridge (UK) LLP
 Drawbridge (UK) LLP Investment ManagersFinance Provides investment advice | Portefeuillebeheerder-Aandelen | 01-01-2006 |
Eyck Capital Management LLP
 Eyck Capital Management LLP Investment ManagersFinance ECM is an active, event-driven, opportunistic manager which seeks to invest in European special situations, distressed debt and stressed debt. The firm focuses on fundamental research-driven long or short investments at the liquid end of the European opportunity set, including bonds, CDS, loans and equities with a low net exposure. Their investment process consists of the development of themes and asset class views in combination with fundamental distressed research. | Algemeen Directeur | - |
Opleiding van Khing Oei
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
11
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Vrije Universiteit Amsterdam
 Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Drawbridge (UK) LLP
Drawbridge (UK) LLP Investment ManagersFinance Provides investment advice | Finance |
Segovia Loan Advisors (UK) LLP
Segovia Loan Advisors (UK) LLP Investment ManagersFinance SLA UK manages various strategies across the capital structure, such as syndicated leveraged loans, high yield bonds, privately negotiated senior secured debt, mezzanine investments, asset-based leasing, and private equity. The firm seeks to provide creative capital solutions and generate attractive risk-adjusted returns for clients. | Finance |
Eyck Capital Management LLP
Eyck Capital Management LLP Investment ManagersFinance ECM is an active, event-driven, opportunistic manager which seeks to invest in European special situations, distressed debt and stressed debt. The firm focuses on fundamental research-driven long or short investments at the liquid end of the European opportunity set, including bonds, CDS, loans and equities with a low net exposure. Their investment process consists of the development of themes and asset class views in combination with fundamental distressed research. | Finance |
Leap Therapeutics, Inc.
 Leap Therapeutics, Inc. BiotechnologyHealth Technology Engages in clinical stage immuno-oncology | Health Technology |
